Modulation of CSF caspase-3 in MSC-NTF cells (NurOwn®) in a Phase 2 ALS study: correlations with CSF biomarkers and clinical response

Poster presented at the 2019 Annual AAN Meeting on the modulation of cerebrospinal fluid caspase-3 in the Phase 2 ALS study.